RxDoctor Payments Data

Agnes Chang

Dermatology · Washington, DCNPI 1245358985

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $101,785 of the $108,863 with a category attached, or 93.5%. AbbVie accounts for 96.0% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2021 at $31,429 and has fallen 60.7% since, to $12,339 in 2025. Among dermatology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$108,863in general payments, 2019–2025

Across 331 payments — averaging $328.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$105K
  • Galderma Laboratories, L.p.$1K
  • Pfizer$407
  • E.r. Squibb & Sons, L.L.C.$399
  • Novartis$321
  • Lilly USA, LLC$185
  • plus $2K from 22 others

What the payments were for

  • Consulting fees$6901%
  • Speaking & faculty fees$101,78593%
  • Food & beverage$6,3656%
  • Education$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$108,863 in reported general payments places this provider in the 90th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$179,527
Medicare patients
325
Services billed
2,614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate17$1,856
Fluorouracil13$1,049
ValacyclovirValacyclovir Hcl24$1,012
Doxycycline Hyclate23$915
Triamcinolone Acetonide27$327

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →